Product Introduction

Tapio Tapinarof 1% Cream is a topical dermatology medication from Dr. Reddy’s Laboratories, formulated with tapinarof 1% as its active ingredient. The packaging identifies it as a dermatological cream and displays the product in a 60 g value pack, with smaller 10 g and 30 g packs also advertised.

Tapinarof is a topical aryl hydrocarbon receptor (AhR) agonist that helps regulate inflammatory pathways and skin-barrier functions. Medicines containing tapinarof are used for specific inflammatory skin conditions under medical supervision. The precise indication and suitability of Tapio should be confirmed from its approved Indian prescribing information and your dermatologist's advice.

For iMedicart customers, this product should be presented as a medicated dermatology cream rather than a general-purpose moisturiser. Use it only as directed by a qualified healthcare professional, following the instructions supplied with the product.

Uses

• Inflammatory skin conditions: Tapinarof is an established topical treatment for plaque psoriasis in certain approved markets.

• Dermatological management: May be prescribed for an appropriate inflammatory skin condition when the treating dermatologist considers tapinarof suitable.

• Skin-barrier support: Tapinarof's mechanism may help regulate biological pathways associated with skin-barrier function.

Important: The exact approved indication for this particular Tapio product should be verified against its Indian package insert and current regulatory labelling. Do not advertise it as a treatment for eczema, acne, fungal infections, or other conditions without product-specific evidence.

Key Ingredients & Full Ingredients

Active ingredient: Tapinarof 1% w/w.

The supplied packaging image confirms the active ingredient and strength but does not show the complete excipient list.

• Tapinarof: The active topical ingredient responsible for the medicine's pharmacological action.

• Other ingredients (excipients): Not legible or listed in the supplied images. Refer to the tube carton or official package insert for the complete formulation.

Do not add an unverified ingredient list to the Shopify product page. The full composition should be entered only after checking the manufacturer's official documentation.

Benefits

• Provides targeted topical treatment through tapinarof 1% as the active ingredient.

• Acts on the aryl hydrocarbon receptor (AhR), a pathway involved in inflammatory responses and skin-barrier regulation.

• May help improve symptoms of an appropriate inflammatory skin condition when prescribed for that indication.

• Offers a cream formulation for application to affected skin.

• Available in a 60 g value pack, according to the promotional image.

• Manufactured by Dr. Reddy’s, a pharmaceutical company with dermatology products.

Treatment response varies by individual. Benefits depend on the diagnosed condition, correct application, and prescribed treatment duration.

Side Effects

Possible side effects associated with topical tapinarof include:

• Redness or irritation at the application site.

• Itching or discomfort of the treated skin.

• Folliculitis (inflammation around hair follicles).

• Headache or other symptoms reported during treatment.

Seek medical advice if irritation persists, symptoms worsen, or a new rash develops. Stop using the cream and seek urgent medical attention if you experience signs of a serious allergic reaction, such as facial swelling or difficulty breathing.

These are potential effects associated with tapinarof treatment generally; they are not a confirmed, product-specific adverse-event list for Tapio.

Product Form

• Dosage form: Topical cream

• Active ingredient: Tapinarof 1% w/w

• Pack size shown: 60 g value pack

• Other pack sizes advertised: 10 g and 30 g

• Route of administration: External use on the skin

• Product category: Dermatology medication

How to Use

1. Read the supplied package insert and follow your dermatologist's instructions.

2. Wash your hands before application, unless your hands are the treatment area.

3. Apply the prescribed amount as a thin layer to the affected skin.

4. Avoid contact with the eyes, mouth, and other mucous membranes. Do not swallow.

5. Wash your hands after application unless the hands are being treated.

6. Use the cream for the prescribed duration. Do not increase the amount or frequency to obtain faster results.

7. If you miss an application, follow the package instructions or ask your pharmacist; do not double the next application.

Dosage note: The exact application frequency and maximum treated area should be confirmed from the official Tapio prescribing information. Do not automatically apply dosing instructions from another tapinarof brand.

How it Works

Tapinarof is an aryl hydrocarbon receptor (AhR) agonist. AhR is a cellular receptor involved in regulating immune responses, inflammation, and the expression of genes that support the skin barrier.

When activated, this pathway can influence inflammatory signalling and the production of certain inflammatory mediators. It can also affect the expression of proteins associated with epidermal differentiation and skin-barrier function.

Through these actions, topical tapinarof can help reduce disease activity in conditions for which it is prescribed. It is not an antifungal, antibiotic, or corticosteroid, and its precise effect depends on the underlying skin condition.

3. Medical & Safety Information

Safety Advice

• Medical supervision: Use only for the condition and duration recommended by a qualified healthcare professional.

• Pregnancy: Human pregnancy data may be limited. Discuss potential benefits and risks with your doctor before use.

• Breastfeeding: Consult your healthcare professional. Avoid applying the cream to the nipple or areas that may come into direct contact with an infant unless specifically advised.

• Alcohol: A clinically significant interaction with alcohol is not established for topical tapinarof. Follow your doctor's advice.

• Driving and machinery: An effect on driving ability is not expected from topical use, but seek advice if you experience symptoms that could impair alertness.

• Kidney or liver conditions: The supplied images do not provide product-specific guidance for these conditions. Inform your doctor about significant kidney or liver disease.

• Broken or infected skin: Seek medical advice before applying to severely damaged skin or an area with a suspected infection.

• Eyes and mucous membranes: Avoid contact. If accidental exposure occurs, rinse thoroughly with water.

• Children: Use only if the product's approved age range and your healthcare professional's instructions permit it.

• Allergies: Do not use if you have a known allergy to tapinarof or any ingredient in the formulation.

Quick Tips

• Apply the cream consistently according to the prescribed regimen.

• Use only the amount required to cover the affected area as instructed.

• Avoid adding other medicated creams to the same area without checking with your dermatologist.

• Keep a record of any new irritation, rash, or other unwanted symptoms.

• Store the product according to the label and keep it out of children's reach.

• Do not share your prescription medication with another person.

• Confirm the pack size, expiry date, batch number, and seal before use.

Fact Box

• Brand: Tapio

• Active ingredient: Tapinarof 1% w/w

• Therapeutic class: Topical aryl hydrocarbon receptor agonist

• Dosage form: Cream

• Route: Topical / external use

• Pack size: 60 g value pack shown

• Other advertised sizes: 10 g and 30 g

• Manufacturer/brand company shown: Dr. Reddy’s

• Prescription status: Confirm the current Indian classification and dispensing requirements before publishing; do not assume OTC status.

• Habit forming: Not expected to be habit forming.

• Diet restrictions: No specific dietary restrictions are generally expected for topical use.

• Alcohol restriction: No established specific alcohol restriction; follow medical advice.

• Suitable for: Only patients whose diagnosed condition and clinical circumstances support its use.

• Storage: Follow the manufacturer's label.

• Use: As directed by a healthcare professional.

Interaction with Drugs

Tapinarof is applied to the skin, so systemic exposure is generally expected to be lower than with an oral medicine. However, that does not establish that every combination is risk-free.

• Other topical medicines: Using additional prescription creams, ointments, or irritating skincare products on the same area may increase irritation or complicate treatment.

• Other psoriasis or inflammatory skin treatments: Tell your dermatologist about all topical and systemic therapies, including corticosteroids, immunomodulators, and biologic medicines.

• Prescription medicines: No specific severe drug interaction can be confirmed from the supplied packaging. Formal interaction data for this exact product may be limited.

• Supplements and herbal products: Inform your healthcare professional about everything you use, particularly if you are receiving other treatments for a skin condition.

Consult a doctor or pharmacist before combining Tapio with another medicated topical product. Do not stop an existing prescribed treatment without medical advice.

4. Business Details

Manufacturer, Importer, and Marketer

The supplied product tube and promotional image provide the following visible information:

• Brand: Tapio

• Active ingredient: Tapinarof 1% Cream

• Company name shown: Dr. Reddy’s

• Manufacturing claim shown in promotional material: Manufactured at a Dr. Reddy’s facility with approvals and accreditations referenced in the promotional image.

Manufacturer: Dr. Reddy’s is identified in the supplied promotional material, but the exact manufacturing entity, full factory address, and manufacturing licence number are not legible in the images.

Importer: Not specified in the supplied images.

Marketer: Dr. Reddy’s is shown as the company associated with the product. The exact legal marketing entity is not confirmed by the supplied images.

Important for Shopify: Before publishing, verify the legal manufacturer, marketer, full address, and licence details from the product carton or official package insert. Do not present an inferred company name or address as a verbatim label transcription.

5. FAQs

1. What is Tapio Tapinarof 1% Cream used for?

Tapio contains tapinarof 1%, a topical medicine that acts on the aryl hydrocarbon receptor. Tapinarof is used for certain inflammatory skin conditions, including plaque psoriasis in approved markets. Confirm the approved indication for this specific product with your dermatologist.

2. How should Tapio Cream be applied?

Apply a thin layer to the affected skin as directed by your healthcare professional and the product leaflet. Avoid the eyes and mucous membranes, and wash your hands after application unless your hands are being treated.

3. Can Tapio Cream cause side effects?

Possible side effects include local irritation, redness, itching, and folliculitis. Contact your doctor if symptoms persist or worsen. Seek urgent care for signs of a serious allergic reaction.

4. Can I use Tapio Cream with other skin treatments?

Possibly, but this depends on the other medicine and the condition being treated. Inform your dermatologist about all creams, ointments, and oral medicines you use before combining treatments.

5. Is Tapio Tapinarof 1% Cream suitable for everyone?

No. Suitability depends on the diagnosed condition, age, medical history, allergies, and the product's approved labelling. Pregnant or breastfeeding individuals and people with sensitive or damaged skin should seek medical advice before use.